Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-195-2 | CAS number: 7446-09-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
The references contained in the sub sectionare merely considered as supplementary information as (i) only observations on isolated organs of the test animals have been reported (ii) mechanistic inverstigations focussed on the biochemical effects of sulfur dioxide exposure, e.g. cytokine levels.
Additional information
Toxicokinetic
Distribution
Studies in Animals
In lung, heart, liver, kidneys, spleen, brain, retina and lens tissue, testis, stomach and intestinal tissues increased lipid peroxidation, changes in lipid profiles, decreased GSH levels and changed activities of antioxidative enzymes were detected, indicating that sulfite or metabolites are readily distributed in the body (Agar et al., 2000a; Haider et al., 1981, 1982, 1985; Kilic, 2003; Langley-Evans et al., 1996; Meng, 2003; Meng and Bai, 2004; Meng and Zhang, 2003; Meng et al., 2003b, c; Wu and Meng, 2003; Yargicoglu et al., 1999).
Metabolism
Due to the high reactivity of bisulfite for disulfide structures, especially in proteins or in oxidized glutathione GSSG, disulfide bonds are cleaved and S-sulfonates are formed (e. g. Langley-Evans et al., 1996). Decreased glutathione levels, found in the lungs and other tissues of rats after exposure to sulfur dioxide, suggest that GSH may be involved in the detoxification process (Langley-Evans et al., 1996).
Irritation
Studies in Animals
Skin & Mucous membranes
Signs of eye irritation were reported when rats or guinea pigs were subacutely exposed to 10 ppm sulfur dioxide for 1 hour daily (Haider et al., 1981, 1982, 1985).
In pigs exposed to 35 ppm sulfur dioxide signs of ocular and nasal irritation appeared initially that declined within 1-2 days (Martin and Willoughby, 1971).
Respiratory tract
In pigs reversible enhancement of signs of irritation, as severe discomfort and laboured inspiration, was observed only when relative humidity neared 100 % or when sulfur dioxide increased accidentally to 100 ppm (Martin and Willoughby, 1971).
Repeated dose toxicity
Studies in Animals
Inhalation
Exposure of Sprague Dawleyratsfor up to 8 months to 1 ppm sulfur dioxide resulted in bronchiolar epithelial hyperplasia at 4 months which was absent at 8 months. A slight impairment of respiratory function was demonstrated at 4 months of exposure as the only examined time point. No significant pathological changes were observed in the nasal cavities. Furthermore no changes were found in parameters associated with immune competence and in spleen weight. Overall the effects were judged as minimal by the authors of the study (Smith et al., 1989). A further study, which specifically examined nose tissue did not reveal any changes after nose-only exposure of F344 rats exposed to 5 ppm (4 weeks, 2 hours/day, 5 days/week: Wolff et al., 1989).
Numerous further studies have investigated effects on the upper and lower respiratory tract. After subacute or subchronic exposure of different animal species to concentrations of 10 ppm and above changes in the nose region included decreased ciliar activity, disappearance of cilia and changes of goblet cell numbers in the respiratory epithelium, squamous metaplasia and basal cell hyperplasia in the nasal epithelium, sloughing of cells, viscous secretion, oedematous swelling (Fowlie et al., 1990; Giddens and Fairchild, 1972; Johnson et al., 1972; Majima et al., 1986; Martin and Willoughby, 1971; Sugiura et al., 1997).
Histological and inflammatory changes as described above have also been found in several species in the trachea and the lower respiratory tract (Asmundsson et al., 1973; Kasé et al., 1982; Krasnowska et al., 1998; Martin and Willoughby, 1971; Miyata et al., 1990; Okuyama et al., 1979; Scanlon et al., 1987; Seltzer et al., 1984; Sueyoshi et al., 2004; Xu et al., 2000; Yamamoto et al., 1970). Lesions characteristic of those seen in human chronic bronchitis were observedin rats, dogs, rabbitsand ferrets after subacute to chronic inhalation of sulfur dioxide at concentrations of 50 ppm and above (Chakrin and Saunders, 1974; Clark et al., 1980; Greene et al., 1984, 1987; Islam et al., 1977; Knauss et al., 1976; Lamb and Reid, 1968; Miller et al., 1985; Morgenroth, 1980; Spicer et al., 1974; Vai et al., 1980; White et al., 1986; Yamamoto, 1970).
Lesions proceeded from the nasal cavity to the trachea and changes increased in severity as exposure time increased (Asmundsson et al., 1973; Greene et al., 1984, 1987; Knauss et al., 1976; Lamb and Reid, 1968; Long et al., 1999; Martin and Willoughby, 1971; Shore et al., 1987; Yamamoto, 1970). During exposure-free recovery periods reversibility was observed for histological changes, cough and mucous hypersecretion (Clark et al., 1980; Giddens and Fairchild, 1972; Johnson et al., 1972; Lamb and Reid, 1968; Scanlon et al., 1987; Seltzer et al., 1984; Vai et al., 1980). In addition, despite continued exposure, in some experiments partial or full reversibility of specific histological changes such as erosion, hyperplasia of epithelium or goblet cells, and increase of mucus cells and mucus production was found (Smith et al., 1989; White et al., 1986; Yamamoto, 1970). Conflicting results were obtained on the effect of sulfur dioxide on particle clearance, but the studies are difficult to compare due to different species, exposure protocols and parameters analysed (Fraser et al., 1968; Greene et al., 1984; 1987; Hirsch et al., 1975; Holma, 1967; Rylander et al., 1971; Wakabayashi et al., 1977; Wolff et al., 1989).In one study phagocytosis of bacteria was not impaired in guinea pigs after subacute exposure to 10 ppm sulfur dioxide (Rylander et al., 1971).
Some more recent studies have investigated oxidative stress after subacute or subchronic exposure(1 or 6 hours daily exposure) to sulfur dioxide(concentration range 5-100 ppmin rats and guinea pigs. In erythrocytes formation of methaemoglobin and sulfhaemoglobin, lipid peroxidation and changes of the antioxidative defense was found (Agar et al., 2000a, b; Baskurt et al. 1994; Dikmenoglu et al., 1991; Etlik et al., 1995, 1997; Gümüslü et al., 1998, 2000, 2001; Kilic, 2003; Kücükatay et al., 2003; Yargicoglu et al., 1999, 2001; Yücel et al., 1998). Furthermore in lung, heart, liver, kidneys, spleen, brain, retina and lens tissue, testis, stomach and intestinal tissues increased lipid peroxidation, decreased GSH levels and changed activities of antioxidative enzymes were detected (Agar et al., 2000; Kilic, 2003; Langley-Evans et al., 1996; Meng, 2003; Meng and Bai, 2004; Meng and Zhang, 2003; Meng et al., 2003; Wu and Meng, 2003; Yargicoglu et al., 1999). Lipid profiles were changed in different regions of the brain, in lung, heart, liver and kidney (Haider et al., 1981, 1982, 1985). Impairment of visual function was indicated by changes in peak latencies and peak amplitudes of visual-evoked potentials which were found in addition to the oxidative changes (Agar et al., 2000a; Kilic, 2003; Yargicoglu et al., 1999, 2001).
Blood pressure of rats was lowered significantly both in a dose- and time-dependent manner (LOAEL 20 ppm) which was interpreted as a functional damage to the cardiovascular system. The NOAEL was 10 ppm (Meng et al., 2003).
An inflammatory response in lung tissue of mice was demonstrated at exposure levels of 5 and 10 ppm by a derangement of the balance between pro-inflammatory cytokines (increased levels of IL-6 and TNF-α1) and anti-inflammatory cytokines (decrease of TGF-β1) (Meng et al., 2005).
In summary many endpoints were affected at 10 ppm in studies where this concentration was the lowest tested. A few studies demonstrated specific changes at 5 or 8 ppm. Only minimal effects were detected at 1 ppm. Based on all these studies the overall LOAEL is 5 ppm.
Acute toxicity
Studies on respiratory effects
Lesions in nasal tissue were induced in mice after 24 hours of exposure to 10ppm (Giddens and Fairchild, 1972).
Studies on lethality
Syrian hamsters (N=6) tolerated 4 to 5-hour-exposures to 40 and 200 ppm sulfur dioxide without mortality (LC0200 ppm), whereas 400 ppm sulfur dioxide were lethal within 45 minutes to 1 day following immediate development of respiratory distress. At autopsy greatest mucosal changes were always seen in the trachea and the larger bronchi but the bronchioles were invariably spared (Asmundsson et al., 1973).
Sensitive populations
The predominant response produced by inhalation of sulfur dioxide is bronchoconstriction by a non-allergic mechanism. It is due to contraction of airway smooth muscle via a parasympathetic reflex as well as release of humoral mediators (e. g. Haji et al., 1996). Mediation by receptors in the nose or larynx is suggested as bronchoconstriction is also induced by nose breathing or after isolated exposure of the upper airways, in a condition when virtually all sulfur dioxide is absorbed in the nose (Hahn et al., 1983; Wang et al., 1996).
Entry adopted from the OECD SIAR on sulfur dioxide without modification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.